Registration, poster set-up and welcome coffee

Conference Opening and Welcome Address

Welcome Address

Session Chair

Keynote Address: Raymond Hamers

From Whole Monoclonal Antibodies to Single Domain Antibodies: Think small

Discovery of Camelid Heavy-chain Only Antibodies and Generation of Nanobodies

Coffee Break and Poster Viewing

Overview of Ig-NARs and Generation of V-NARs

Session Chair

Single Domain Antibodies Targeting the BBB and the Brain Vasculature

Cell Penetrating Anti-GFAP VHH Spontaneously Cross the BBB and Specifically Recognizes Astrocytes

Networking Lunch and Poster Viewing

A Nanobody targeting the N-terminal alpha-helical Multimerization Domain of HIV-1 Rev prevents Viral Production

A Novel and Unique Method to introduce Nanobodies Inside a Cell

Session Chair

Lactobodies: Lactobacilli Expressing Variable Domain of Llama Heavy-chain Antibody Fragments (Lactobodies) Confer Protection against Rotavirus-induced Diarrhea.

Engineering of Aggregation-resistant Human Antibody Domains by Phage Display

Pulmonary Delivered Domain Antibodies: anti-TNFR1 dAb for Lung Diseases

Coffee Break and Poster Viewing

Session Chair

OC 1 - Inhibition of Actin Filament Capping by a CapG SDA restrains Cellular Migration and Invasion

OC2 - Development of SDA against the HIV-1 ENV Glycoprotein to inhibit Infection of CD4+ Cells

OC 3 - ART-2 Blocking Nanobodies Protect Regulatory T Cells from NAD-induced Cell Death

OC 4 - Analysis of BBB Permeablity for Nanobodies using Microdialysis

Closing Remarks from Co-Chairs

Networking Drink with Lite Bites

Session Chair

Improved Tumor Targeting of Anti-EGFR Nanobodies through Albumin Binding

Engineering Nanobodies for Improved Treatment of Infectious Diseases

Using dAbs to Control in Vivo Exposure of Metabolic Peptides

Session Chair

Inhibitory and Stimulatory Nanobodies Against a Nucleotide-gated Ion Channel

Coffee Break and Poster Viewing

CXCR4-specific Nanobodies Selectively and Potently Inhibit Chemotaxis and HIV Entry

'Engineering Nanobodies that Bind to Human Lysozyme and Inhibit its Conversion to Amyloid Fibrils: Prospects in Systemic and Neurodegenerative Protein Aggregation Diseases

Llama Single Domain Antibodies as Rugged Countermeasures for Filoviruses and BoNT

Networking Lunch and Poster Viewing

Nanobodies with G protein like properties stabilize a G Protein-Coupled Receptor Active State

Session Chair

Connecting Biochemistry and Cell Biology with Nanobodies

Molecular Imaging using Nanobodies

Session Chair

Considerations for the Manufacture of Nanobodies from Pipeline into the Clinic

Nanobodies: Roadmap to Clinical Proof of Concept. Review of Phase I Experience.

Closing Remarks from the Co-Chairs

Presentation of the Young Scientist Awards & Closure of the Symposium